Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Promising flavonoid discovered by Dutch investigators for preventing doxorubicin cardiotoxicity

April 5, 2000

WP-769: a doxorubicin analogue that combines oral activity and enhanced effect against topo II

April 5, 2000

Novel tubulin-binding antimitotic agent characterized in vitro by Abbott scientists

April 5, 2000

Celgene's IMiDs and thalidomide show activity as COX-2 inhibitors

April 5, 2000

T-900607, a novel tubulin-binding agent, on track for clinical development

April 4, 2000

Simplified halichondrin B analogues retain potent anticancer activity

April 4, 2000

SB-238039: a new antitumor agent that appears to act as a Jak2 inhibitor

April 4, 2000

Novel inhibitors of cyclin-dependent kinases discovered by Korean researchers

April 4, 2000

EntreMed commences phase I clinical trial of 2-methoxyestradiol

April 4, 2000

ImClone Systems awarded SBIR grant for antiangiogenesis research

April 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...